Influenza Vaccine GSK1247446A

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

InfluenzaInfluenza, Human

Phase 2

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

CompletedNCT00385840

GlaxoSmithKlineInfluenza

Start: 2006-10-20End: 2007-02-05Updated: 2018-06-08

Revaccination With Influenza Vaccine GSK1247446A

CompletedNCT00545025

GlaxoSmithKlineInfluenza, Influenza, Human

Start: 2007-10-15End: 2007-12-12Updated: 2019-06-26